ADA2 and inflammatory bowel disease: We further demonstrate that reduction in inflammation in pan-DR3 deficient recipients was accompanied by a reduction in TL1A-induced intestinal fibrosis, an important feature of experimental IBD in our model (and reflecting human CD disease risk) that had yet to be corroborated in host-DR3-deficiency.